# 參考文獻

> **狀態**：初稿整理中（最後統一編號與格式）
> **最後更新**：2026-01-30

---

## 全論文引用清單

### 診斷標準與指引

| # | 引用 | 縮寫 | 用於 |
|---|------|------|------|
| 1 | James, P. A., et al. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults (JNC 8). *JAMA*, 311(5), 507-520. | JNC 8 | Ch2 高血壓診斷標準 |
| 2 | American Diabetes Association. (2025). Standards of Care in Diabetes—2025. *Diabetes Care*, 48(Suppl 1). | ADA 2025 | Ch2 糖尿病診斷標準 |
| 3 | National Cholesterol Education Program. (2002). ATP III Final Report. *Circulation*, 106(25), 3143-3421. | ATP III | Ch2 血脂異常診斷標準 |

### 資料集來源

| # | 引用 | 用於 |
|---|------|------|
| 4 | Luo, Y., Wu, Q., Meng, R., et al. (2024). Associations of serum uric acid with cardiovascular disease risk factors: a retrospective cohort study in southeastern China. *BMJ Open*, 13(9), e073930. https://doi.org/10.1136/bmjopen-2023-073930 | Ch2 Ch3 資料集原始論文 |
| 5 | Luo, Y., Wu, Q., Meng, R., et al. (2023). Associations of serum uric acid with cardiovascular disease risk factors [Dataset]. *Dryad Digital Repository*. https://doi.org/10.5061/dryad.z08kprrk1 | Ch3 資料集下載來源 |

### 疾病預測研究（Ch2 2.1）

| # | 引用 | 用於 |
|---|------|------|
| 6 | Sun, D., et al. (2017). Recent development of risk-prediction models for incident hypertension: An updated systematic review. *PLoS ONE*, 12(10), e0187240. | Ch2 2.1.1, 2.3 |
| 7 | Kanegae, H., et al. (2020). Highly precise risk prediction model for new-onset hypertension using artificial intelligence techniques. *The Journal of Clinical Hypertension*, 22(3), 453-461. | Ch2 2.1.1, 2.2.2 |
| 8 | Ye, C., et al. (2018). Prediction of Incident Hypertension Within the Next Year: Prospective Study Using Statewide EHR and ML. *JMIR*, 20(1), e22. | Ch2 2.1.1 |
| 9 | Wang, H., Chu, Y., & Jang, J. (2024). Next-visit prediction and prevention of hypertension using large-scale routine health checkup data. *PLoS ONE*, 19(11), e0312370. | Ch2 2.1.1 |
| 10 | Liu, C., et al. (2024). Prediction of Type 2 Diabetes Onset Using Machine Learning from EMR. *Diagnostics*, 15(1), 72. | Ch2 2.1.2, 2.4.1 |
| 11 | Chen, Y., et al. (2025). A Dual-Framework Approach Combining SHAP and δ-FPG for Prediabetes. *Diagnostics*, 15(19), 2507. | Ch2 2.1.2, 2.2.2, 2.4.1, 2.4.2 |
| 12 | Alaa, A. M., et al. (2019). Cardiovascular disease risk prediction using automated machine learning. *Nature Medicine*, 25, 1477-1482. | Ch2 2.4.1, 表 2-1 |
| 13 | Dinh, A., et al. (2019). A data-driven approach to predicting diabetes and cardiovascular disease with machine learning. *BMC Medical Informatics and Decision Making*, 19(1), 211. | Ch2 2.4.1, 表 2-1 |

### 方法論（Ch2 2.3-2.4）

| # | 引用 | 用於 |
|---|------|------|
| 14 | Fisher, R. A. (1936). The use of multiple measurements in taxonomic problems. *Annals of Eugenics*, 7(2), 179-188. | Ch2 2.3.3 LDA |
| 15 | Hung, C., et al. (2021). Prediction of Masked Hypertension and Masked Uncontrolled Hypertension Using Machine Learning. *Frontiers in Cardiovascular Medicine*, 8, 778306. | Ch2 2.4.2 SVM |
| 16 | Taiwan MTL (2025). 多任務學習慢性病預測. | Ch2 2.4.3 神經網路 |

### 類別不平衡與評估指標（Ch2 2.5, Ch3 3.5）

| # | 引用 | 用於 |
|---|------|------|
| 17 | He, H., & Garcia, E. A. (2009). Learning from imbalanced data. *IEEE Transactions on Knowledge and Data Engineering*, 21(9), 1263-1284. | Ch2 2.5 |
| 18 | Chawla, N. V., et al. (2002). SMOTE: Synthetic Minority Over-sampling Technique. *JAIR*, 16, 321-357. | Ch2 2.5.1 |
| 19 | Saito, T., & Rehmsmeier, M. (2015). The Precision-Recall Plot Is More Informative than the ROC Plot When Evaluating Binary Classifiers on Imbalanced Datasets. *PLoS ONE*, 10(3), e0118432. | Ch3 3.5.2 PR-AUC 未採用說明 |

### 第一章引用 — 公共衛生與流行病學

| # | 引用 | 用於 |
|---|------|------|
| 20 | World Heart Federation. (2023). *World Heart Report 2023: Confronting the World's Number One Killer*. WHF. | Ch1 [^1] 心血管死亡統計 |
| 21 | 國民健康署（2022）。2017-2020 國民營養健康狀況變遷調查。衛生福利部。 | Ch1 [^2] 台灣三高盛行率 |
| 22 | 國民健康署（2025）。成人預防保健服務擴大至 30 歲公告。衛生福利部。 | Ch1 [^3] 健檢年齡下修 |
| 23 | World Health Organization. (2023). *Global report on hypertension: the race against a silent killer*. WHO. | Ch1 [^4] 全球高血壓報告 |
| 24 | Ohira, T., & Iso, H. (2013). Cardiovascular disease epidemiology in Asia. *Circulation Journal*, 77(7), 1646-1652. | Ch1 [^5] 亞洲心血管流行病學 |
| 25 | Kario, K., et al. (2021). Epidemiological Features of Cardiovascular Disease in Asia. *JACC: Asia*, 1(1), 1-13. | Ch1 [^5] 亞洲心血管流行病學 |
| 26 | Kim, H. S., et al. (2025). Metabolic diseases in the East Asian populations. *Nature Reviews Endocrinology*. | Ch1 [^6] 東亞代謝疾病 |

### 第一章引用 — 代謝症候群

| # | 引用 | 用於 |
|---|------|------|
| 27 | Jacobs, M. J., et al. (2005). Coronary heart disease risk factors, metabolic syndrome and hypertension. *Current Opinion in Cardiology*, 20(4), 270-274. | Ch1 [^7] 三高共病 |
| 28 | Patti, A. M., et al. (2023). Links between metabolic syndrome and hypertension. *Journal of Cardiovascular Development and Disease*, 10(1), 20. | Ch1 [^7] 三高共病 |
| 29 | Alberti, K. G., et al. (2009). Harmonizing the metabolic syndrome: A joint interim statement. *Circulation*, 120(16), 1640-1645. | Ch1 [^8] 代謝症候群定義 |

---

## 待確認事項

| 項目 | 狀態 |
|------|------|
| #4 Luo vs Zhu 作者名確認 → 已確認第一作者為 Luo（BMJ Open 原文核實） | ✅ 完成 |
| #16 Taiwan MTL (2025) 需補正式引用格式 | ⚠️ 待確認 |
| #25 JACC: Asia 的完整作者與頁碼需核實 | ⚠️ 待確認 |
| #18 Chawla et al. (2002) SMOTE — 格式已確認 ✅ | ✅ 完成 |

---

## 引用統計

| 章節 | 引用數 | 對應編號 |
|------|--------|----------|
| Ch1 | 10 篇 | #20-29 |
| Ch2 | 16 篇 | #1-16 |
| Ch3 | 1 篇 | #19（另引用 Ch2 文獻） |
| Ch4 | 0 篇 | （引用 Ch2/Ch3 文獻） |
| **合計** | **29 篇**（去重後） | |

---

*備註：此為初稿對照表，待論文完成時統一整理格式（APA 或學校指定格式）並重新編號。目前編號僅供內部對照用。*
